Therapuetic Areas:Ophthalmology
Age Range:18 - Any
Start Date:November 2014
End Date:November 2018

Use our guide to learn which trials are right for you!

A Prospective Evaluation of the Novel Glaucoma Premium Edition Software for Spectral Domain Optical Coherence Tomography

The investigators prospectively evaluate the new glaucoma premium edition (GMPE) software
for spectral domain optical coherence tomography (SDOCT) and if this software is superior to
the conventional one that is currently used for SDOCT.

The new GMPE software can now identify the ocular structures without input from the operator
thus reducing operator induced errors. It also measures the thickness of the entire optic
nerve head so as to allow for another anatomic area of the eye to be measured for assessment
of glaucoma. In addition, it permits collection of retinal nerve fiber layer thickness data
in three concentric circles instead of just one in order to account for different sizes of
optic nerves.

Subjects who are receiving routine SDOCT (CPT 92133) will be recruited from the Duke Eye
Center and its associated satellite clinics. Following informed consent, subjects undergo
additional imaging using the SDOCT-GMPE software at the Duke Eye Center and its associated
satellite clinics. The imaging results may be used in clinical care for the subjects.

Inclusion Criteria:

- capable and willing to provide consent

- history of clinically-diagnosed glaucoma

- at least 18 years of age

Exclusion Criteria:

- unable or unwilling to give consent

- under 18 years of age
We found this trial at
Durham, North Carolina 27710
Phone: 919-684-2841
Durham, NC
Click here to add this to my saved trials